特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
955622

薬物スクリーニング検査サービスの世界市場 - 機会分析と業界予測:2020年~2027年

Drug Screening Laboratory Services Market by Service type,, Sample Type, End User : Global Opportunity Analysis and Industry Forecast, 2020-2027 by Service type,, Sample Type, End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 220 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.60円
薬物スクリーニング検査サービスの世界市場 - 機会分析と業界予測:2020年~2027年
出版日: 2020年07月01日
発行: Allied Market Research
ページ情報: 英文 220 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬物スクリーニング検査サービスの市場規模は、2019年の67億2043万米ドルから、2027年までに70億5091万米ドルに達し、2020年~2027年のCAGRで9.4%の成長が予測されています。若者や高齢者のアルコール消費の増加、職場での麻薬や違法薬物の使用の増加、処方薬の過剰使用などが、薬物スクリーニング検査サービス市場の成長を後押しする重要な要素です。

当レポートでは、世界の薬物スクリーニング検査サービス市場について調査分析し、市場概要、市場規模と予測、セグメント別市場分析、地域別市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • ポーターのファイブフォース分析
  • 主な調査結果
  • 規則
  • 市場シェア分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 市場に対するCOVID-19の影響

第4章 薬物スクリーニング検査サービス市場:サービスの種類別

  • 概要
  • 職場の薬物検査
  • 臨床毒性検査

第5章 薬物スクリーニング検査サービス市場:標本の種類別

  • 概要
  • 尿
  • 口腔液
  • 毛髪
  • その他

第6章 薬物スクリーニング検査サービス市場:エンドユーザー別

  • 概要
  • 小売
  • 石油・ガス
  • 交通
  • 人材派遣
  • 政府
  • その他の職場
  • 病院検査室
  • 臨床検査室
  • その他の検査室

第7章 薬物スクリーニング検査サービス市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ・中東・アフリカ

第8章 企業プロファイル

  • ABBOTT LABORATORIES (ALERE)
  • QUEST DIAGNOSTICS INCORPORATED
  • CLINICAL REFERENCE LABORATORY, INC
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • STERLING HEALTHCARE OPCO, LLC/CORDANT HEALTH SOLUTIONS
  • ACM GLOBAL LABORATORIES, INC
  • OMEGA LABORATORIES LIMITED
  • PSYCHEMEDICS CORPORATION
  • PRECISION DIAGNOSTICS
  • MILLENNIUM HEALTH
  • MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
図表

LIST OF TABLES

  • TABLE 01.DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES TYPE, 2019-2027 ($MILLION)
  • TABLE 02.DRUG SCREENING LABORATORY SERVICES MARKET FOR WORKPLACE DRUG TESTING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 03.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL TOXICOLOGY TESTING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027 ($MILLION)
  • TABLE 05.URINE DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.ORAL FLUID DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 07.HAIR DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.OTHERS DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 10.DRUG SCREENING LABORATORY SERVICES MARKET FOR RETAIL, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.DRUG SCREENING LABORATORY SERVICES MARKET FOR OIL & GAS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.DRUG SCREENING LABORATORY SERVICES MARKET FOR DRUG TESTING LABORATORIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.DRUG SCREENING LABORATORY SERVICES MARKET FOR STAFFING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.DRUG SCREENING LABORATORY SERVICES MARKET FOR GOVERNMENT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER WORKPLACES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.DRUG SCREENING LABORATORY SERVICES MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL LABORATORIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER LABORATORIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 21.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 22.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 23.U.S. DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 24.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 25.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 26.CANADA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 27.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 28.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 29.MEXICO DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 30.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 31.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 32.NORTH AMERICA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 33.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 34.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 35.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 36.GERMANY DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 37.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 38.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 39.FRANCE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 40.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 41.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 42.UK DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 43.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 44.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 45.ITALY DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 46.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 47.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 48.SPAIN DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 49.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 50.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 51.REST OF EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 52.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 53.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 54.EUROPE DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 55.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 56.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 57.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 58.JAPAN DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 59.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 60.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 61.CHINA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 62.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 63.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 64.AUSTRALIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 65.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 66.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 67.INDIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 68.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 69.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 70.REST OF ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 71.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 72.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 73.ASIA-PACIFIC DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 74.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 75.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 76.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 77.BRAZIL DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 78.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 79.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 80.SOUTH AFRICA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 81.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 82.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 83.SAUDI ARABIA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 84.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 85.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 86.REST OF LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 87.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICES, 2019-2027
  • TABLE 88.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE, 2019-2027
  • TABLE 89.LAMEA DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER, 2019-2027
  • TABLE 90.ABBOTT: COMPANY SNAPSHOT
  • TABLE 91.ABBOTT: OERATING SEGMENT
  • TABLE 92.QUEST DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 93.QUEST DIAGNOSTICS: OPERATING BUSINESS SEGMENTS
  • TABLE 94.CLINICAL REFERENCE LABORATORY: COMPANY SNAPSHOT
  • TABLE 95.LABCORP: COMPANY SNAPSHOT
  • TABLE 96.LABCORP: OPERATING SEGMENTS
  • TABLE 97.CORDANT: COMPANY SNAPSHOT
  • TABLE 98.ACM GLOBAL LABORATORIES: COMPANY SNAPSHOT
  • TABLE 99.OMEGA LABORATORIES: COMPANY SNAPSHOT
  • TABLE 100.PSYCHEMEDICS: COMPANY SNAPSHOT
  • TABLE 101.PSYCHEMEDICS: OPERATING SEGMENTS
  • TABLE 102.PRECISION DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 103.MILLENNIUM HEALTH: COMPANY SNAPSHOT
  • TABLE 104.MAYO CLINIC LABORATORIES: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01.GLOBAL DRUG SCREENING MARKET SEGMENTATION
  • FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 04.LOW THREAT OF SUBSTITUTES
  • FIGURE 05.MODEARTE THREAT OF NEW ENTRANTS
  • FIGURE 06.HIGH INTENSITY OF RIVALRY
  • FIGURE 07.TOP INVESTMENT POCKETS
  • FIGURE 08.MARKET SHARE ANALYSIS, 2019
  • FIGURE 09.DRIVER, RESTRAINSTS AND OPPORTUNITIES
  • FIGURE 10.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR WORKPLACE DRUG TESTING, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 11.DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL TOXICOLOGY TESTING, BY COUNTRY, 2019 &2027 (%)
  • FIGURE 12.COMPARATIVE ANALYSIS OF URINE DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 13.COMPARATIVE ANALYSIS ORAL FLUID DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF HAIR DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF OTHERS DRUG SCREENING LABORATORY SERVICES MARKET, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET RETAIL, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OIL & GAS, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR TRANSPORTATION, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR STAFFING, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR GOVERNMENT, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER WORKPLACES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 22.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 23.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 24.COMPARATIVE ANALYSIS OF DRUG SCREENING LABORATORY SERVICES MARKET FOR OTHER LABORATORIES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 25.ABBOTT: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 26.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 27.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 28.QUEST DIAGNOSTICS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 29.QUEST DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 30.LABCORP: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 31.LABCORP: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 32.LABCORP: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 33.PSYCHEMEDICS: REVENUE, 2017-2019 ($MILLION)
  • FIGURE 34.PSYCHEMEDICS: NET SALE BY SEGMENT 2019 (%)
  • FIGURE 35.PSYCHEMEDICS: NET SALE BY REVENUE 2019 (%)
目次
Product Code: A06642

Title:
Drug Screening Laboratory Services Market by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027 by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global drug screening laboratory services market was valued at $6,720.43 million in 2019, and is projected to reach $7,050.91 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.

Drug screening is a quick and painless technical analysis of biological samples such as blood, hair, and urine to diagnose presence of illegal, prescription drugs, or its metabolites. Drug screening devices have improved, owing to the introduction of new technologies that offer users with precise and accurate results. Drug screening tests are adopted by employers to maintain a free, healthy, and sober workforce that helps maintain high productivity and an appropriate work environment. Rise in alcohol consumption among youth & elderly population, increase in use of narcotics & illicit drugs at workplace, and over use of prescribed drugs are the key factors that fuel growth of the drug screening laboratory services market. Moreover, technological advancements in drug screening products, surge in applications of these services, and increase in competition among providers boost growth of the global market. Furthermore, rise in government funding & initiatives for drug testing, increase in patient awareness toward drug screening policies, and adverse effects of drugs & alcohol are other factors that contribute toward growth of the market. However, possible manipulation of drug screening tests, and poor demand in under developed countries are expected to hinder growth of the market.

The drug screening laboratory services market is segmented into service type, sample type, end user, and region. On the basis of service, the market is categorized into workplace drug testing and clinical toxicology. By sample type, it is further divided into urine, oral fluid, breath, hair, and others. On the basis of end user, it is divided into retail, oil & gas, transportation, staffing, government, other workplaces, hospital laboratories, clinical laboratories, and other laboratories. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global drug screening laboratory services market along with the current trends and future estimations to elucidate the imminent investment pockets.

A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.

Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the key segments of the industry helps to understand the application and products of drug screening used across the globe.

Key market players and their strategies have been analysed to understand the competitive outlook of the drug screening laboratory services market.

KEY MARKET SEGMENTS

By Service Type

  • Workplace Drug Testing
  • Clinical Toxicology Testing

By Sample Type

  • Urine Sample
  • Oral Fluid Sample
  • Hair Sample
  • Others

By End User

  • Retail
  • Oil and Gas
  • Transportation
  • Staffing
  • Government
  • Other Workplaces
  • Hospital Laboratories
  • Clinical Laboratories
  • Other Laboratories

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • KEY MARKET PLAYERS
  • Abbott Laboratories (Alere Inc.)
  • Acm Global Laboratories, Inc
  • Clinical Reference Laboratory
  • Quest Diagnostics Incorporated.
  • Laboratory Corporation Of America Holdings
  • Psychemedics
  • Millennium Health
  • Mayo Laboratories For Medical Education and Research
  • Omega Laboratories
  • Precision Diagnostics
  • Cordant Health Solutions

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key Benefits for Stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Porter's five force analysis
  • 3.3.Key findings
    • 3.3.1.Top Investment Pockets
  • 3.4.Regulations
  • 3.5.Market share analysis
  • 3.6.Market dynamics
    • 3.6.1.Drivers
      • 3.6.1.1.Stringent government regulations regarding drug abuse
      • 3.6.1.2.Rise in awareness against drug abuse
      • 3.6.1.3.Surge in funding for drug screening
    • 3.6.2.Restraints
      • 3.6.2.1.Consideration of drug screening as a violation of rights
      • 3.6.2.2.Negative impact of COVID-19 pandemic on the drug screening market
    • 3.6.3.Opportunities
      • 3.6.3.1.Development of novel drug screening tests
      • 3.6.3.2.Tapping emerging markets
  • 3.7.COVID-19 impact on the market

CHAPTER 4:DRUG SCREENING LABORATORY SERVICES MARKET, BY SERVICE TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Workplace drug testing
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Clinical toxicology testing
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country

CHAPTER 5:DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Urine
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Oral fluid
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Hair
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country
  • 5.5.Others
    • 5.5.1.Market size and forecast
    • 5.5.2.Market analysis, by country

CHAPTER 6:DRUG SCREENING LABORATORY SERVICES MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Retail
    • 6.2.1.Market size and forecast
    • 6.2.2.Market analysis, by country
  • 6.3.Oil & gas
    • 6.3.1.Market size and forecast
    • 6.3.2.Market analysis, by country
  • 6.4.Transportation
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country
  • 6.5.Staffing
    • 6.5.1.Market size and forecast
    • 6.5.2.Market analysis, by country
  • 6.6.Government
    • 6.6.1.Market size and forecast
    • 6.6.2.Market analysis, by country
  • 6.7.Other workplaces
    • 6.7.1.Market size and forecast
    • 6.7.2.Market analysis, by country
  • 6.8.Hospital laboratories
    • 6.8.1.Market size and forecast
    • 6.8.2.Market analysis, by country
  • 6.9.Clinical laboratories
    • 6.9.1.Market size and forecast
    • 6.9.2.Market analysis, by country
  • 6.10.Other laboratories
    • 6.10.1.Market size and forecast
    • 6.10.2.Market analysis, by country

CHAPTER 7:DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by country
      • 7.2.2.1.U.S.
      • 7.2.2.1.1.U.S. drug screening laboratory services market, by services
      • 7.2.2.1.2.U.S. drug screening laboratory services market, by sample type
      • 7.2.2.1.3.U.S. drug screening laboratory services market, by end user
      • 7.2.2.2.Canada
      • 7.2.2.2.1.Canada drug screening laboratory services market, by services
      • 7.2.2.2.2.Canada drug screening laboratory services market, by sample type
      • 7.2.2.2.3.Canada drug screening laboratory services market, by end user
      • 7.2.2.3.Mexico
      • 7.2.2.3.1.Mexico drug screening laboratory services market, by services
      • 7.2.2.3.2.Mexico drug screening laboratory services market, by sample type
      • 7.2.2.3.3.Mexico drug screening laboratory services market, by end user
    • 7.2.3.North America market size and forecast, by services
    • 7.2.4.North America market size and forecast, by sample type
    • 7.2.5.North America market size and forecast, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by country
      • 7.3.2.1.Germany
      • 7.3.2.1.1.Germany drug screening laboratory services market, by services
      • 7.3.2.1.2.Germany drug screening laboratory services market, by sample type
      • 7.3.2.1.3.Germany drug screening laboratory services market, by end user
      • 7.3.2.2.France
      • 7.3.2.2.1.France drug screening laboratory services market, by services
      • 7.3.2.2.2.France drug screening laboratory services market, by sample type
      • 7.3.2.2.3.France drug screening laboratory services market, by end user
      • 7.3.2.3.UK
      • 7.3.2.3.1.UK drug screening laboratory services market, by services
      • 7.3.2.3.2.UK drug screening laboratory services market, by sample type
      • 7.3.2.3.3.UK drug screening laboratory services market, by end user
      • 7.3.2.4.Italy
      • 7.3.2.4.1.Italy drug screening laboratory services market, by services
      • 7.3.2.4.2.Italy drug screening laboratory services market, by sample type
      • 7.3.2.4.3.Italy drug screening laboratory services market, by end user
      • 7.3.2.5.Spain
      • 7.3.2.5.1.Spain drug screening laboratory services market, by services
      • 7.3.2.5.2.Spain drug screening laboratory services market, by sample type
      • 7.3.2.5.3.Spain drug screening laboratory services market, by end user
      • 7.3.2.6.Rest of Europe
      • 7.3.2.6.1.Rest of Europe drug screening laboratory services market, by services
      • 7.3.2.6.2.Rest of Europe drug screening laboratory services market, by sample type
      • 7.3.2.6.3.Rest of Europe drug screening laboratory services market, by end user
    • 7.3.3.Europe market size and forecast, by services
    • 7.3.4.Europe market size and forecast, by sample type
    • 7.3.5.Europe market size and forecast, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by country
      • 7.4.2.1.Japan
      • 7.4.2.1.1.Japan drug screening laboratory services market, BY SERVICES
      • 7.4.2.1.2.Japan drug screening laboratory services market, by sample type
      • 7.4.2.1.3.Japan drug screening laboratory services market, by end user
      • 7.4.2.2.China
      • 7.4.2.2.1.China drug screening laboratory services market, by services
      • 7.4.2.2.2.China drug screening laboratory services market, by sample type
      • 7.4.2.2.3.China drug screening laboratory services market, by end user
      • 7.4.2.3.Australia
      • 7.4.2.3.1.Australia drug screening laboratory services market, by services
      • 7.4.2.3.2.Australia drug screening laboratory services market, by sample type
      • 7.4.2.3.3.Australia drug screening laboratory services market, by end user
      • 7.4.2.4.India
      • 7.4.2.4.1.India drug screening laboratory services market, by services
      • 7.4.2.4.2.India drug screening laboratory services market, by sample type
      • 7.4.2.4.3.India drug screening laboratory services market, by end user
      • 7.4.2.5.Rest of Asia-Pacific
      • 7.4.2.5.1.Rest of Asia-Pacific drug screening laboratory services market, by services
      • 7.4.2.5.2.Rest of Asia-Pacific drug screening laboratory services market, by sample type
      • 7.4.2.5.3.Rest of Asia-Pacific drug screening laboratory services market, by end user
    • 7.4.3.Asia-Pacific market size and forecast, by services
    • 7.4.4.Asia-Pacific market size and forecast, by sample type
    • 7.4.5.Asia-Pacific market size and forecast, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.Market size and forecast, by country
      • 7.5.2.1.Brazil
      • 7.5.2.1.1.Brazil drug screening laboratory services market, by services
      • 7.5.2.1.2.Brazil drug screening laboratory services market, by sample type
      • 7.5.2.1.3.Brazil drug screening laboratory services market, by end user
      • 7.5.2.2.South Africa
      • 7.5.2.2.1.South Africa drug screening laboratory services market, by services
      • 7.5.2.2.2.South Africa drug screening laboratory services market, by sample type
      • 7.5.2.2.3.South Africa drug screening laboratory services market, by end user
      • 7.5.2.3.Saudi Arabia
      • 7.5.2.3.1.Saudi Arabia drug screening laboratory services market, by services
      • 7.5.2.3.2.Saudi Arabia drug screening laboratory services market, by sample type
      • 7.5.2.3.3.Saudi Arabia drug screening laboratory services market, by end user
      • 7.5.2.4.Rest of LAMEA
      • 7.5.2.4.1.Rest of LAMEA drug screening laboratory services market, by services
      • 7.5.2.4.2.Rest of LAMEA drug screening laboratory services market, by sample type
      • 7.5.2.4.3.Rest of LAMEA drug screening laboratory services market, by end user
    • 7.5.3.LAMEA market size and forecast, by services
    • 7.5.4.LAMEA market size and forecast, by sample type
    • 7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.ABBOTT LABORATORIES (ALERE)
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Business performance
  • 8.2.QUEST DIAGNOSTICS INCORPORATED
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Business performance
  • 8.3.CLINICAL REFERENCE LABORATORY, INC
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
  • 8.4.LABORATORY CORPORATION OF AMERICA HOLDINGS
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Business performance
  • 8.5.STERLING HEALTHCARE OPCO, LLC/CORDANT HEALTH SOLUTIONS
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
  • 8.6.ACM GLOBAL LABORATORIES, INC
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Key strategic moves and developments
  • 8.7.OMEGA LABORATORIES LIMITED
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
  • 8.8.PSYCHEMEDICS CORPORATION
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Business performance
    • 8.8.5.Key strategic moves and developments
  • 8.9.PRECISION DIAGNOSTICS
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
  • 8.10.MILLENNIUM HEALTH
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Key strategic moves and developments
  • 8.11.MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    • 8.11.1.Company overview
    • 8.11.2.Company snapshot
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.